BACKGROUND
Predicting individual treatment responses to anti-calcitonin gene-related peptide monoclonal antibodies (CGRP-mAbs) in migraine remains challenging.
OBJECTIVE
To develop a machine learning (ML) model for predicting 3-month treatment response to CGRP-mAbs and to evaluate its practical clinical utility in im...
Masahito Katsuki, M. Tatsumoto, Tomokazu Shimazu et al.· Headache· 0 citations
Abstract Migraine and epilepsy frequently coexist, but evidence on the safety of calcitonin gene‐related peptide (CGRP)‐targeting therapies in people with epilepsy is lacking. We evaluated long‐term migraine and epilepsy outcomes in a real‐world multicenter retrospective cohort of adults with comorbid migraine and epil...
Marina Romozzi, Andrea Burgalassi, Francesco Ceriello et al.· Epilepsia Open· 0 citations
Background: Headache and facial pain may occur in patients with meningioma, but their diagnostic significance is often underestimated when pain resembles a primary headache phenotype or occurs in a patient with a long-standing history of tension-type headache. Cavernous sinus meningiomas are particularly relevant in he...
Matteo Palermo, Marina Romozzi, Vittoria Viglione et al.· Confinia cephalalgica (Milan...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.